Patrik Medstrand
71 – 80 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
New insights are game-changers in HIV-2 disease management – Authors' reply
- Contribution to journal › Letter
-
Mark
Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein-Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2-Infected Individuals
- Contribution to journal › Article
-
Mark
Transmission dynamics study of tuberculosis isolates with whole genome sequencing in southern Sweden
- Contribution to journal › Article
-
Mark
Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection
- Contribution to journal › Article
-
Mark
Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau : a prospective open cohort study
- Contribution to journal › Article
-
Mark
Hydrogen peroxide vapour treatment inactivates norovirus but has limited effect on post-treatment viral RNA levels
- Contribution to journal › Article
-
Mark
Quantification of HIV-2 DNA in Whole Blood
- Contribution to journal › Article
- 2018
-
Mark
Detection of airborne noroviruses in hospitals and lab experiments
(2018) AEROSOLS 2018
- Contribution to conference › Abstract
-
Mark
Viability of aerosolized murine norovirus in experimental setup
(2018) IAC, International Aerosol Conference 2018
- Contribution to conference › Abstract
-
Mark
Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA) : A Randomized Controlled Trial
- Contribution to journal › Article
